Exploring the Future of Live Biotherapeutics

Day 16 of Road to the Max: Australia saw us reunited with the Interceptor, thanks to the expert team at NAS. Eager to regain momentum, we headed north out of Brisbane to Coolum Beach for a visit with Servatus, an Australian biothech developing live biotherapeutics for a range of autoimmune disorders. After a tour of the lab led by Nicolas Pichon, General Manager, we had the pleasure of taking Mark Williams, CEO of Servatus, for a spin in the Interceptor. Mark shared more about Servatus’s innovative work and its focus on autoimmune diseases, giving us a glimpse into the future of biotherapeutics.

Road to the Max University Tour

Next, we made our way to the Queensland Brain Institute (QBI) at the University of Queensland. We met with Rachel de las Heras, Ultrasound Product Development Manager, who gave us an inside look at QBI’s groundbreaking research in treatments for neurodegenerative, psychiatric, and age-related brain diseases. To close out the day, we visited the Queensland University of Technology, where we took a closer look at their synthetic biology lab. It was an inspiring day filled with cutting-edge science, innovation, and new discoveries, all fueled by the roar of the Interceptor. Stay tuned as we near the final stretch of our journey on the Road to the Max: Australia!